AU2001275032A1 - Methods for detecting dna damage and screening for cancer therapeutics - Google Patents

Methods for detecting dna damage and screening for cancer therapeutics

Info

Publication number
AU2001275032A1
AU2001275032A1 AU2001275032A AU7503201A AU2001275032A1 AU 2001275032 A1 AU2001275032 A1 AU 2001275032A1 AU 2001275032 A AU2001275032 A AU 2001275032A AU 7503201 A AU7503201 A AU 7503201A AU 2001275032 A1 AU2001275032 A1 AU 2001275032A1
Authority
AU
Australia
Prior art keywords
screening
methods
dna damage
cancer therapeutics
detecting dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001275032A
Inventor
Thanos Halazonetis
Linda B. Schultz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wistar Institute of Anatomy and Biology
Original Assignee
Wistar Institute of Anatomy and Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wistar Institute of Anatomy and Biology filed Critical Wistar Institute of Anatomy and Biology
Publication of AU2001275032A1 publication Critical patent/AU2001275032A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5748—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving oncogenic proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001275032A 2000-06-01 2001-05-30 Methods for detecting dna damage and screening for cancer therapeutics Abandoned AU2001275032A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20871600P 2000-06-01 2000-06-01
US60208716 2000-06-01
PCT/US2001/017471 WO2001091629A2 (en) 2000-06-01 2001-05-30 Methods for detecting dna damage and screening for cancer therapeutics

Publications (1)

Publication Number Publication Date
AU2001275032A1 true AU2001275032A1 (en) 2001-12-11

Family

ID=22775732

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001275032A Abandoned AU2001275032A1 (en) 2000-06-01 2001-05-30 Methods for detecting dna damage and screening for cancer therapeutics

Country Status (3)

Country Link
US (2) US7217532B2 (en)
AU (1) AU2001275032A1 (en)
WO (1) WO2001091629A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005216013B2 (en) 2004-01-30 2010-11-11 Dana Farber Cancer Institute Method for determination and quantification of radiation or genotoxin exposure
US20100248226A1 (en) * 2006-08-04 2010-09-30 Graham Dellaire Methods for measuring cell response to dna damaging agents using promyelocytic leukemia protein nuclear bodies
MX2011012043A (en) * 2009-05-13 2012-03-29 Protein Delivery Solutions Llc Pharmaceutical system for trans-membrane delivery.
US20150017092A1 (en) * 2012-03-15 2015-01-15 The Regents Of The University Of California Devices and methods for determining sensitivity to radiation
US9931634B2 (en) 2014-02-27 2018-04-03 The Regents Of The Univeristy Of California High throughput DNA damage quantification of human tissue with home-based collection device
KR102125005B1 (en) * 2017-10-27 2020-06-22 한양대학교 에리카산학협력단 Novel use of 53bp1
WO2019089623A1 (en) * 2017-10-30 2019-05-09 Children's Hospital Medical Center Fusion proteins for use in improving gene correction via homologous recombination

Also Published As

Publication number Publication date
US20040023235A1 (en) 2004-02-05
US20070178044A1 (en) 2007-08-02
WO2001091629A3 (en) 2002-04-11
WO2001091629A2 (en) 2001-12-06
US7217532B2 (en) 2007-05-15

Similar Documents

Publication Publication Date Title
AU2001273840A1 (en) Detection of variations in the DNA methylation profile
EP1156324A4 (en) Sample discriminating method
AU2001242280A1 (en) Method for detecting cytosine methylation in dna samples
AU2002225807A1 (en) Object detection
AU2001288268A1 (en) Near object detection system
AU2002220898A1 (en) Ligand detection method
AU2001296554A1 (en) Fluorescence detection
AU2627201A (en) Methods and reagents for facilitating transcription
AU2001271720A1 (en) Methods and compositions for determining gene function
AU2002224328A1 (en) Methods and compositions for detecting cancers associated with methylation of hmlh1promoter dna
IL149676A0 (en) Methods and kits for determining nucleotide variations
AU1465801A (en) Methods for cancer prognosis and diagnosis
AU7494900A (en) Signal counting for in situ hybridization
AU2001242277A1 (en) Method for detecting cytosine methylation in DNA samples
AU2002363259A1 (en) Method for the detection of cytosine methylation in immobilised DNA samples
AU2001281633A1 (en) Detection method
AU2001288853A1 (en) Methods of detecting cancer based on prostasin
AU8323801A (en) Method and system for detecting hidden edges
AU2000237154A1 (en) Method for detecting and killing epithelial cancer cells
AUPR050700A0 (en) Detection method
AUPQ667800A0 (en) Detection method
AU2001275032A1 (en) Methods for detecting dna damage and screening for cancer therapeutics
AUPQ664300A0 (en) Macromolecule detection
AU2002213164A1 (en) Detection of dna damage
AU5867901A (en) Method for detecting tumors